CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
Recruiting · NCT06787560 · Registry updated 2025-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder | Recruiting | Early phase 1 | 2025-01-22 | NCT06787560 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yake Biotechnology Ltd. | 30 |
| Zhejiang University | 194 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The first affiliated hospital of medical college of zhejiang university | Hangzhou | China | 13 |